Znanstveni rad - Pregledni rad
Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment
Pharmaceutics, 13 (2021), 9; 1481. https://doi.org/10.3390/pharmaceutics13091481

Primorac, Dragan; Čemerin, Martin; Matišić, Vid; Molnar, Vilim; Strbad, Marko; Girandon, Lenart; Zenić, Lucija; Knežević, Miomir; Minger, Stephen; Polančec, Denis

Povezani objekti
COVID-19 | Virtualna zbirka
Citirajte ovaj rad

Primorac, D., Čemerin, M., Matišić, V., Molnar, V., Strbad, M., Girandon, L. ... Polančec, D. (2021). Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment. Pharmaceutics, 13. (9). doi: 10.3390/pharmaceutics13091481

Primorac, Dragan, et al. "Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment." Pharmaceutics, vol. 13, br. 9, 2021. https://doi.org/10.3390/pharmaceutics13091481

Primorac, Dragan, Martin Čemerin, Vid Matišić, Vilim Molnar, Marko Strbad, Lenart Girandon, Lucija Zenić, Miomir Knežević, Stephen Minger i Denis Polančec. "Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment." Pharmaceutics 13, br. 9 (2021). https://doi.org/10.3390/pharmaceutics13091481

Primorac, D., et al. (2021) 'Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment', Pharmaceutics, 13(9). doi: 10.3390/pharmaceutics13091481

Primorac D, Čemerin M, Matišić V, Molnar V, Strbad M, Girandon L, i sur.. Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment. Pharmaceutics [Internet]. 16.09.2021. [pristupljeno 18.05.2022.];13(9). doi: 10.3390/pharmaceutics13091481

D. Primorac, et al., "Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment", Pharmaceutics, vol. 13, br. 9, Rujan 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:165701. [Citirano: 18.05.2022.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.